Association of genetic polymorphisms in XRCC4, XRCC5, XRCC6 and XRCC7 in cervical cancer susceptibility from rural population: a hospital based case-control study

Kailas D. Datkhile, Madhavi N. Patil, Pratik P. Durgawale, Kalpita S. Korbu, Shreepad A. Joshi, Satish V. Kakade


Background: Cervical cancer is a major concern of health risk, moreover the leading cause of cancer causing deaths in women of rural India. This study was aimed to assess the risk of cervical cancer development in association with polymorphisms in XRCC4, XRCC5, XRCC6 and XRCC7 genes in rural population of south-western Maharashtra.

Methods: This study included 350 cervical cancer proven cases and 400 age and sex matched controls. We used polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to analyze the association XRCC4, XRCC6 and XRCC7 gene polymorphisms with cervical cancer development in women of Western Maharashtra.

Results: The result from our study showed that allele frequencies of selected genes were not statistically different between the groups for XRCC4, XRCC5 and XRCC6. 6721 >T allele of XRCC7 (6721G>T) (OR= 2.34; 95% CI= (2.34 (1.60-3.43); p= <0.0001) significantly increased the risk of cervical cancer.

Conclusions: This study indicates that XRCC7 gene polymorphisms play a role in modifying genetic susceptibility of individuals towards cervical cancer among women from rural Maharashtra. This case-control study also revealed negative association of XRCC6 gene in cervical carcinogenesis in the rural Indian population.


Cervical cancer, Genetic polymorphisms, PCR-RFLP

Full Text:



World Health Organization, World Health Organization. Management of Substance Abuse Unit. Global status report on alcohol and health, 2014. World Health Organization; 2014.

Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. International J women's health. 2015;7:405.

Martínez-Nava GA, Fernández-Niño JA, Madrid-Marina V, Torres-Poveda K. Cervical cancer genetic susceptibility: A systematic review and meta-analyses of recent evidence. PloS one. 2016 Jul 14;11(7):e0157344.

Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiology and Prevention Biomarkers. 2002 Dec 1;11(12):1513-30.

Mari PO, Florea BI, Persengiev SP, Verkaik NS, Brüggenwirth HT, Modesti M, et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proceedings of the National Academy of Sciences. 2006 Dec 5;103(49):18597-602.

Li R, Yang Y, An Y, Zhou Y, Liu Y, Yu Q, et al. Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma. Carcinogenesis. 2011 Feb 8;32(4):530-6.

Mandal RK, Kapoor R, Mittal RD. Polymorphic variants of DNA repair gene XRCC3 and XRCC7 and risk of prostate cancer: a study from North Indian population. DNA and cell biology. 2010 Nov 1;29(11):669-74.

García-Closas M, Egan KM, Newcomb PA, Brinton LA, Titus-Ernstoff L, Chanock S, et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Human genetics. 2006 May 1;119(4):376.

Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ. A role for XRCC4 in age at diagnosis and breast cancer risk. Cancer Epidemiology and Prevention Biomarkers. 2006 Jul 1;15(7):1306-10.

Tseng HC, Tsai MH, Chiu CF, Wang CH, Chang NW, Huang CY, et al. Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. Anticancer research. 2008 May 1;28(3A):1687-91.

Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer research. 2003 May 15;63(10):2440-6.

Hsia TC, Liu CJ, Chu CC, Hang LW, Chang WS, Tsai CW, et al. Association of DNA Double–strand Break Gene XRCC6 Genotypes and Lung Cancer in Taiwan. Anticancer research. 2012 Mar 1;32(3):1015-20.

Hsu NY, Wang HC, Wang CH, Chang CL, Chiu CF, Lee HZ, et al. Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan. Cancer Biomarkers. 2009 Jan 1;5(4-5):159-65.

Chang CH, Chang CL, Tsai CW, Wu HC, Chiu CF, Wang RF, et al. Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Research. 2009 May 1;29(5):1777-82.

Lim JW, Kim H, Kim KH. Expression of Ku70 and Ku80 mediated by NF-κB and cyclooxygenase-2 is related to proliferation of human gastric cancer cells. J Biological Chemistry. 2002 Nov 29;277(48):46093-100.

Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A, et al. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Inter J Oncol. 2004 Aug 1;25(2):461-8.

Tonotsuka N, Hosoi Y, Miyazaki S, Miyata G, Sugawara K, Mori T, et al. Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium. Inter J Mol Med. 2006 Sep 1;18(3):441-7.

Chang HW, Kim SY, Yi SL, Son SH, Moon SY, Kim JH, et al. Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck. Oral oncology. 2006 Nov 1;42(10):979-86.

Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y, et al. Polymorphisms of DNA repair genes and risk of glioma. Cancer research. 2004 Aug 15;64(16):5560-3.

Wang SY, Peng L, Li CP, Li AP, Zhou JW, Zhang ZD, Liu QZ. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer. Inter J Urol. 2008 Jun 1;15(6):534-9.

Rahimi M, Fayaz S, Fard-Esfahani A, Modarressi MH, Akrami SM, Fard-Esfahani P. The role of Ile3434Thr XRCC7 gene polymorphism in Differentiated Thyroid Cancer risk in an Iranian population. Iranian Biomed J. 2012 Oct;16(4):218.

Bau DT, Tseng HC, Wang CH, Chiu CF, Hua CH, Wu CN, et al. Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. Oral oncology. 2008 Nov 1;44(11):1047-51.

Tseng RC, Hsieh FJ, Shih CM, Hsu HS, Chen CY, Wang YC. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end‐joining pathway genes. Cancer. 2009 Jul 1;115(13):2939-48.

Hsia TC, Liu CJ, Chu CC, Hang LW, Chang WS, Tsai CW, et al. Association of DNA Double-strand Break Gene XRCC6 Genotypes and Lung Cancer in Taiwan. Anticancer research. 2012 Mar 1;32(3):1015-20.

Sturgis EM, Zhao C, Zheng R, Wei Q. Radiation response genotype and risk of differentiated thyroid cancer: a case‐control analysis. Laryngoscope. 2005 Jun 1;115(6):938-45.

Mandal RK, Singh V, Kapoor R, Mittal RD. Do polymorphisms in XRCC4 influence prostate cancer susceptibility in North Indian population?. Biomarkers. 2011 May 1;16(3):236-42.

Mittal RD, Gangwar R, Mandal RK, Srivastava P, Ahirwar DK. Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer. Molecular biology reports. 2012 Feb 1;39(2):1667-75.

Gangwar R, Ahirwar D, Mandhani A, Mittal RD. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?. Mutation Research/Genetic Toxicology Environmental Mutagenesis. 2009 Dec 31;680(1):56-63.

Singh A, Singh N, Behera D, Sharma S. Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy. Molecular biology reports. 2018 Feb 3:1-9.